Research libraryMOLEKUL / SOURCE RECORD

RU2709503C1: Selank in acute cold-water hypothermia models — RU2709503C1

L. A. Andreeva, V. P. Vdovichenko, E. A. Nemersky, A. Yu. Petrovskaya, A. K. Petrovsky, N. A. Smirnov, V. N. Fedorov, T. B. Fedorova · 2019 · RU2709503C1 · patent family 69006996

Published 2019-12-18.

Patent / reported experimentsFull text availableSource linked

Related evidence maps: Military & occupational ↗

Reported patent results

Reported findings

Applicant claims use of Selank for resistance to acute cooling, with separate rat swimming and survival examples.

20 rats in free swimming and 36 in a separate 60-minute 9°C flotation-collar model. Intranasal Selank 200 µg/kg, timing varied by arm.

Reported findings and study figures · Original patent, selected methods and examples checked
MeasureResultComparison, timing and statistics
Free swimming · Example 123% longer active swimming than saline10 rats per arm at 9°C; reported p<0.05.
Post-exposure arm · Example 240% survived the subsequent observation periodOnly 25% of saline controls survived the first hour and all died by day 2. Patent reports a 3.2-fold first-hour survival comparison.
Pre- and post-exposure scheduleNo reported improvement in final survivalDistinct from the post-exposure-only arm.

Animal patent experiments. Human treatment of hypothermia is outside the evidence.

Source for the extracted data ↗ · Checked 2026-11-09

Patent claims and provenance

Use. Applicant claims use of Selank for resistance to acute cooling, with separate rat swimming and survival examples.

Animal patent experiments. Human treatment of hypothermia is outside the evidence.

Publication
RU2709503C1 ↗ · 2019-12-18
Earliest priority / filing
2019-05-23 / 2019-05-23
Original applicant / assignee
Not established from accessed metadata
Indexed status
Not shown; official status unverified · checked 2026-11-09
Patent family
69006996 · family publications are related filings, not independent studies.
Original title, inventors and related publications

Применение пептида Thr-Lys-Pro-Arg-Pro-Gly-Pro (селанк) для повышения резистентности организма к острой гипотермии

Inventors: L. A. Andreeva; V. P. Vdovichenko; E. A. Nemersky; A. Yu. Petrovskaya; A. K. Petrovsky; N. A. Smirnov; V. N. Fedorov; T. B. Fedorova.

RU2709503C1

Original patent PDF ↗

Patent collection and status interpretation →

Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.

Methods, limitations & source review

Study limitations

  • Animal patent experiments. Human treatment of hypothermia is outside the evidence.
  • Animal patent experiments. Human treatment of hypothermia is outside the evidence.
  • Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
  • Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Document format: Original patent text and indexed metadata

Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.

Related-report group: patent-family-69006996. Reports in this group are not assumed to be independent trials.

Source access and review scope

Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.

Recorded source-check date: 2026-11-09. This date does not imply a completed systematic review.

Source type: Patent publication

Open original source or index record ↗

Citation and original source

Original source: L. A. Andreeva, V. P. Vdovichenko, E. A. Nemersky, A. Yu. Petrovskaya, A. K. Petrovsky, N. A. Smirnov, V. N. Fedorov, T. B. Fedorova. RU2709503C1: Selank in acute cold-water hypothermia models — RU2709503C1 RU2709503C1 · patent family 69006996 2019.

Molekul research summary: https://molekul.io/research/patent-ru2709503c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards